GB2347349A8 - A synergistic composition comprising mussel protein extract and glycosaminoglycan suitable for treatment of arthritis - Google Patents

A synergistic composition comprising mussel protein extract and glycosaminoglycan suitable for treatment of arthritis

Info

Publication number
GB2347349A8
GB2347349A8 GB9904672A GB9904672A GB2347349A8 GB 2347349 A8 GB2347349 A8 GB 2347349A8 GB 9904672 A GB9904672 A GB 9904672A GB 9904672 A GB9904672 A GB 9904672A GB 2347349 A8 GB2347349 A8 GB 2347349A8
Authority
GB
United Kingdom
Prior art keywords
glycosaminoglycan
arthritis
treatment
protein extract
synergistic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9904672A
Other versions
GB2347349A (en
GB9904672D0 (en
Inventor
John Eric Croft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MCFARLANE LAB NEW ZEALAND Ltd
Original Assignee
MCFARLANE LAB NEW ZEALAND Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NZ314867A priority Critical patent/NZ314867A/en
Application filed by MCFARLANE LAB NEW ZEALAND Ltd filed Critical MCFARLANE LAB NEW ZEALAND Ltd
Priority to GB9904672A priority patent/GB2347349A/en
Publication of GB9904672D0 publication Critical patent/GB9904672D0/en
Publication of GB2347349A publication Critical patent/GB2347349A/en
Publication of GB2347349A8 publication Critical patent/GB2347349A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9904672A 1997-05-21 1999-03-01 A synergistic composition comprising mussel protein extract and glycosaminoglycan suitable for treatment of arthritis Withdrawn GB2347349A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ314867A NZ314867A (en) 1997-05-21 1997-05-21 Glucosamine and mussel extract compositions for use as anti-inflammatories
GB9904672A GB2347349A (en) 1997-05-21 1999-03-01 A synergistic composition comprising mussel protein extract and glycosaminoglycan suitable for treatment of arthritis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ314867A NZ314867A (en) 1997-05-21 1997-05-21 Glucosamine and mussel extract compositions for use as anti-inflammatories
GB9904672A GB2347349A (en) 1997-05-21 1999-03-01 A synergistic composition comprising mussel protein extract and glycosaminoglycan suitable for treatment of arthritis

Publications (3)

Publication Number Publication Date
GB9904672D0 GB9904672D0 (en) 1999-04-21
GB2347349A GB2347349A (en) 2000-09-06
GB2347349A8 true GB2347349A8 (en) 2000-10-17

Family

ID=26315199

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9904672A Withdrawn GB2347349A (en) 1997-05-21 1999-03-01 A synergistic composition comprising mussel protein extract and glycosaminoglycan suitable for treatment of arthritis

Country Status (2)

Country Link
GB (1) GB2347349A (en)
NZ (1) NZ314867A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1227826E (en) * 1999-07-06 2004-02-27 Foodscience Corp METHODS AND COMPOSITIONS FOR THE SUPPORT REGENERATION AND REPARATION OF CONJUNCTIVE TISSUES
GB0508991D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Veterinary composition
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
MX2018000335A (en) 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin.
US10568938B2 (en) 2015-07-20 2020-02-25 Jiangyin Bengt I. Samuelsson Institute Of Life Science Co., Ltd. Mussel adhesive protein product and applications thereof in suppression of skin inflammations
WO2017011986A1 (en) 2015-07-20 2017-01-26 赵兵 Air filter
WO2017028025A1 (en) * 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 Mussel adhesive protein product and use thereof for inhibiting mucosal inflammation
AU2019243671A1 (en) * 2018-03-27 2020-10-22 Sanford Limited Bioactive green-lipped mussel extracts and uses thereof
AU2021221725A1 (en) * 2021-08-25 2023-03-16 Beyond Capital LP Improvements in and relating to compositions for alleviating the effects/symptoms of inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010061B1 (en) * 1978-09-25 1983-07-13 Stuart John Mc Farlane Pharmaceutical preparations containing a mollusc extract
AUPM740594A0 (en) * 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
SE9702993L (en) * 1997-08-18 1999-02-19 Micro Active Protein In Sweden Antimicrobial composition

Also Published As

Publication number Publication date
GB2347349A (en) 2000-09-06
GB9904672D0 (en) 1999-04-21
NZ314867A (en) 1999-04-29

Similar Documents

Publication Publication Date Title
EG20753A (en) Synergistic composition
IL129556A0 (en) Pharmaceutical compositions and methods for stimulating neurite growth
EP0918787A4 (en) Compositions and methods for antisense inhibition of protein translation
ZA964733B (en) Ob protein compositions and methods
AU5439996A (en) Compositions and methods for treating pain
IL134699A0 (en) Protein composition and process for isolating a protein composition from a muscle source
HK1009401A1 (en) Synergistic combinations
AU1678995A (en) Synergistic antifungal protein and compositions containing same
HK1033653A1 (en) Synergistic composition and use thereof
HK1084831A1 (en) Herbicidal synergistic composition and method of used control
NZ312748A (en) Synergistic herbicidal composition and method of use thereof
IL123132A0 (en) Synergistic mixtures of natural products
GB2347349A8 (en) A synergistic composition comprising mussel protein extract and glycosaminoglycan suitable for treatment of arthritis
HUP0002961A3 (en) Synergistic fungicidal mixture and their use
HUP0003786A3 (en) Synergistic herbicidal methods and compositions
EP0921803A4 (en) Methods for preventing and treating pestivirus infection and associated diseases
SG65766A1 (en) Composition for preventing and treating gingival diseases
GB9513551D0 (en) Anti-bacterial synergistic composition
HU9401579D0 (en) Methods for administering biological agents and microparticle compositions
HUP9902556A3 (en) Herbicidal synergistic composition and method for its use
HK1065923A1 (en) Herbicidal synergistic composition and method of used control
GB9615684D0 (en) Expression of toxic protein
HUP9600327A3 (en) Pharmaceutical composition for treating or profilacting meteoropathy and different kinetoses
ZA983187B (en) Synergistic mixtures of selected amino acids
GB9608927D0 (en) Method of treatment and pharmaceutical composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)